エンフルラン市場：投与経路別、最終用途別-世界予測2024-2030年

エンフルラン市場規模は2023年に2億639万米ドルと推計され、2024年には2億1,570万米ドルに達し、CAGR 4.59%で2030年には2億8,270万米ドルに達すると予測されます。

エンフルラン（化学名：2-クロロ-1,1,2-トリフルオロエチルジフルオロメチルエーテル）は、吸入麻酔薬であり、歴史的に全身麻酔を誘発・維持するために医療で利用されてきました。中枢神経系のさまざまな神経伝達系の活性を調節することにより作用し、可逆的に意識と感覚を喪失させる。エンフルランは、中等度の作用発現と持続時間を含むその有利な薬物動態学的プロファイルにより、かつては手術の現場で広く使用されていましたが、安全性と有効性のプロファイルが改善された新しい薬剤の開発により、その用途は時間の経過とともに減少しています。エンフルランのニーズは、世界の外科手術の増加、医療行為の進歩、ヘルスケアインフラへの多額の投資によってもたらされています。厳しい規制基準、潜在的な副作用、安全性プロファイルが改善された新型麻酔薬との競合といった課題に直面しているもの、エンフルラン市場には有望な成長機会があります。これには、副作用を低減した先進的で安全な麻酔薬処方の探求、精密投与のためのデータ分析やAIなどの技術革新の活用、ヘルスケア水準が上昇する新興市場への進出などが含まれます。環境に優しい代替品に焦点を当てた調査と技術革新、標的ドラッグデリバリーのためのナノテクノロジーの潜在的統合は、環境問題に対処し患者の転帰を改善しながら市場の成長軌道を強化するための変革的方向性を示しています。

投与経路：吸入によるエンフルラン投与の増加

エンフルランは主に吸入により投与されます。全身麻酔導入および維持のための強力な吸入麻酔薬です。吸入投与により、エンフルランは呼吸器系から直接吸収され、迅速な麻酔導入が可能となります。この経路は、外科手術中に麻酔の深さを調節できるため、コントロールしやすく好ましいです。呼吸機能と麻酔薬濃度を注意深くモニターすることは、患者の安全性と効果的な麻酔管理を確保するために極めて重要です。エンフルランには経口投与経路が適用されます。エンフルランは経口摂取用に処方されたり、推奨されることがあります。経口摂取は十分な麻酔のための適切なメカニズムを提供します。

エンドユース：病院におけるエンフルランの使用方法の進化

外来手術センターでは、エンフルランは、より新しく、肝毒性が少なく、代謝の早い吸入麻酔薬が開発されたため、あまり使用されていません。しかし、低資源環境や特定の患者集団におけるエンフルランの役割を完全に否定することはできないです。このような施設では、患者の早期回復と退院が優先されるため、体内からのクリアランスが早く、術後の副作用が最小限に抑えられる麻酔薬を使用する必要があります。病院はエンフルランを投与する主要な場であり、特にその使用を注意深くモニターできる、より専門的な外科あるいは集中治療室です。エンフルランは特定のシナリオにおいて、その効力と費用対効果から選択されることがあります。エンフルランは、腎毒性や、特にてんかんの素因を持つ患者における発作誘発の可能性に対する懸念から、その人気は低下しているもの、特に新しい薬剤が法外に高価であったり、入手できなかったりする国々では、依然として麻酔薬の武器として使用されています。

地域別インサイト

南北アメリカでは、強固なヘルスケア・インフラ、一人当たり医療費の高さ、全身麻酔を必要とする外科手術の重視などにより、エンフルランが大きな市場を形成しています。欧州連合（EU）では、加盟国間のヘルスケア政策の違いがエンフルランの市場浸透に影響を与えています。政府によるヘルスケア支出が多い国では、麻酔プロトコールにおけるエンフルランの使用率が高くなっています。EMEA（欧州・中東・アフリカ）地域は、高度なヘルスケア施設を有する石油国から、医療インフラが限られた新興経済諸国まで、多様な市場を形成しています。経済的な余裕がない地域では、麻酔薬の利用が進まない可能性があります。アジア太平洋地域では、医療セクターの急速な拡大と外科手術の急増により、エンフルラン市場が発展しています。インドのエンフルラン市場は、医療インフラの成長、医療施設へのアクセスの向上、コストへの敏感さなどの影響を受けています。インド市場におけるエンフルランの普及には、手頃な価格と有効性のバランスが重要な役割を果たします。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはエンフルラン市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、エンフルラン市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された蓄積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.エンフルラン市場の市場規模および予測は？

2.エンフルラン市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.エンフルラン市場の技術動向と規制枠組みは？

4.エンフルラン市場における主要ベンダーの市場シェアは？

5.エンフルラン市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患や事故の発生率が世界的に増加
    • 短期から中期の麻酔を必要とする手術において、麻酔科医の間でエンフルランの好みが高まっている
  • 抑制要因
    • 新しく進歩した麻酔薬の出現
  • 機会
    • 麻酔の投与とモニタリング技術における技術革新
    • 生分解性で環境に優しい代替品の調査が進行中
  • 課題
    • エンフルランの使用を規制する規制当局の監視と厳格なガイドライン
• 市場セグメンテーション分析
  • 投与経路：吸入によるエンフルランの投与量の増加
  • 最終用途：病院によるエンフルランの使用法の進化
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 エンフルラン市場：投与経路別

• 吸入
• オーラル

第7章 エンフルラン市場：最終用途別

• 外来手術センター
• 病院

第8章 南北アメリカのエンフルラン市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のエンフルラン市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのエンフルラン市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • サンメド、バイエア・メディカルの呼吸器・麻酔消耗品事業の買収を完了
• 戦略分析と提言

第12章 競争力のあるポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. ENFLURANE MARKET RESEARCH PROCESS
• FIGURE 2. ENFLURANE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ENFLURANE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ENFLURANE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL ENFLURANE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. ENFLURANE MARKET DYNAMICS
• FIGURE 7. GLOBAL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL ENFLURANE MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL ENFLURANE MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. AMERICAS ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 12. AMERICAS ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES ENFLURANE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 14. UNITED STATES ENFLURANE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. ENFLURANE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 20. ENFLURANE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ENFLURANE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ENFLURANE MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL ENFLURANE MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL ENFLURANE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL ENFLURANE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL ENFLURANE MARKET SIZE, BY INHALATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL ENFLURANE MARKET SIZE, BY INHALATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL ENFLURANE MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL ENFLURANE MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL ENFLURANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL ENFLURANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL ENFLURANE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL ENFLURANE MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. AMERICAS ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 20. AMERICAS ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 21. AMERICAS ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 22. AMERICAS ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 23. AMERICAS ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 24. AMERICAS ENFLURANE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 25. ARGENTINA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 26. ARGENTINA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 27. ARGENTINA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 28. ARGENTINA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 29. BRAZIL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 30. BRAZIL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 31. BRAZIL ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 32. BRAZIL ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 33. CANADA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 34. CANADA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 35. CANADA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 36. CANADA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 37. MEXICO ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 38. MEXICO ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 39. MEXICO ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 40. MEXICO ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 41. UNITED STATES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 42. UNITED STATES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 43. UNITED STATES ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 44. UNITED STATES ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 45. UNITED STATES ENFLURANE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 46. UNITED STATES ENFLURANE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 48. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 50. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 52. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 53. AUSTRALIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 54. AUSTRALIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 55. AUSTRALIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 56. AUSTRALIA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 57. CHINA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 58. CHINA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 59. CHINA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 60. CHINA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 61. INDIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 62. INDIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 63. INDIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 64. INDIA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 65. INDONESIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 66. INDONESIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 67. INDONESIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 68. INDONESIA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 69. JAPAN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 70. JAPAN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 71. JAPAN ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 72. JAPAN ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 73. MALAYSIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 74. MALAYSIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 75. MALAYSIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 76. MALAYSIA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 77. PHILIPPINES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 78. PHILIPPINES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 79. PHILIPPINES ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 80. PHILIPPINES ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 81. SINGAPORE ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 82. SINGAPORE ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 83. SINGAPORE ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 84. SINGAPORE ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 86. SOUTH KOREA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 88. SOUTH KOREA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 89. TAIWAN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 90. TAIWAN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 91. TAIWAN ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 92. TAIWAN ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 93. THAILAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 94. THAILAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 95. THAILAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 96. THAILAND ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 97. VIETNAM ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 98. VIETNAM ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 99. VIETNAM ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 100. VIETNAM ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 107. DENMARK ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 108. DENMARK ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 109. DENMARK ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 110. DENMARK ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 111. EGYPT ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 112. EGYPT ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 113. EGYPT ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 114. EGYPT ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 115. FINLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 116. FINLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 117. FINLAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 118. FINLAND ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 119. FRANCE ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 120. FRANCE ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 121. FRANCE ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 122. FRANCE ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 123. GERMANY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 124. GERMANY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 125. GERMANY ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 126. GERMANY ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 127. ISRAEL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 128. ISRAEL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 129. ISRAEL ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 130. ISRAEL ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 131. ITALY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 132. ITALY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 133. ITALY ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 134. ITALY ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 135. NETHERLANDS ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 136. NETHERLANDS ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 137. NETHERLANDS ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 138. NETHERLANDS ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 139. NIGERIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 140. NIGERIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 141. NIGERIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 142. NIGERIA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 143. NORWAY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 144. NORWAY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 145. NORWAY ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 146. NORWAY ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 147. POLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 148. POLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 149. POLAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 150. POLAND ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 151. QATAR ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 152. QATAR ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 153. QATAR ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 154. QATAR ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 155. RUSSIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 156. RUSSIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 157. RUSSIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 158. RUSSIA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 160. SAUDI ARABIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 162. SAUDI ARABIA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 164. SOUTH AFRICA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 166. SOUTH AFRICA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 167. SPAIN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 168. SPAIN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 169. SPAIN ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 170. SPAIN ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 171. SWEDEN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 172. SWEDEN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 173. SWEDEN ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 174. SWEDEN ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 175. SWITZERLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 176. SWITZERLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 177. SWITZERLAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 178. SWITZERLAND ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 179. TURKEY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 180. TURKEY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 181. TURKEY ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 182. TURKEY ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 188. UNITED KINGDOM ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 190. UNITED KINGDOM ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 191. ENFLURANE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 192. ENFLURANE MARKET, FPNV POSITIONING MATRIX, 2023

[180 Pages Report] The Enflurane Market size was estimated at USD 206.39 million in 2023 and expected to reach USD 215.70 million in 2024, at a CAGR 4.59% to reach USD 282.70 million by 2030.

Enflurane, chemically designated as 2-chloro-1,1,2-trifluoroethyl difluoromethyl ether, is an inhalational anesthetic historically utilized in medicine to induce and maintain general anesthesia. It operates by modulating the activity of various neurotransmitter systems in the central nervous system, leading to a reversible loss of consciousness and sensation. While enflurane was once widely used in surgical settings for its advantageous pharmacokinetic profile, including a moderate onset and duration of action, its application has diminished over time due to the development of newer agents with improved safety and efficacy profiles. Enflurane's need is driven by the increasing number of surgical interventions worldwide, advancements in medical practices, and significant investments in healthcare infrastructure. Despite facing challenges such as stringent regulatory standards, potential side effects, and competition from newer anesthetics with improved safety profiles, the enflurane market holds promising growth opportunities. These include the exploration of advanced, safer anesthetic formulations with reduced side effects, leveraging technological innovations such as data analytics and AI for precision dosing, and expanding into emerging markets with rising healthcare standards. Research and innovation focusing on eco-friendly alternatives and the potential integration of nanotechnology for targeted drug delivery represent transformative directions for enhancing the market's growth trajectory while addressing environmental concerns and improving patient outcomes.

Route of Administration: Increasing administration of enflurane via inhalation

Enflurane is primarily administered through inhalation. It is a potent inhalational anesthetic agent for general anesthesia induction and maintenance. Inhalation administration allows enflurane to be directly absorbed through the respiratory system, providing a rapid onset of anesthesia. This route is preferred for its controllability and the capacity to adjust the depth of anesthesia during surgical procedures. Careful monitoring of respiratory function and anesthetic concentration is critical to ensure patient safety and effective anesthesia management. The oral route of administration is applicable for enflurane. Enflurane is sometimes formulated or recommended for oral consumption. Oral consumption provides an appropriate mechanism for adequate anesthesia.

End-Use: Evolving usage of enflurane by hospitals

In ambulatory surgical centers, enflurane is infrequently used due to the development of newer, less hepatotoxic, and more rapidly metabolized inhalational anesthetics. However, its role in certain low-resource settings or specific patient populations cannot be entirely discounted. These centers prioritize quick patient recovery and discharge, necessitating using anesthetics that allow rapid clearance from the body and minimal post-operative side effects. Hospitals represent a primary setting for administering enflurane, particularly in more specialized surgical or intensive care units where its use can be closely monitored. Enflurane may be chosen for its potency and cost-effectiveness in specific scenarios. Despite its declining popularity due to concerns over nephrotoxicity and the potential for seizure induction, especially in patients predisposed to epilepsy, it remains in the arsenal of anesthetics, particularly in countries where newer agents are prohibitively expensive or unavailable.

Regional Insights

In the Americas, enflurane has a significant market driven by robust healthcare infrastructure, high per capita healthcare expenditure, and a strong emphasis on surgical procedures requiring general anesthesia. In the European Union, varying healthcare policies across member states affect enflurane's market penetration. Nations with more significant governmental healthcare spending exhibit higher rates of enflurane utilization in anesthesia protocols. The EMEA region presents a diverse market ranging from oil-rich nations with advanced healthcare facilities to developing economies with limited medical infrastructure. Affordability issues may drive its use in less affluent areas. In the Asia Pacific, the enflurane market is evolving due to the rapidly expanding healthcare sector and surge in surgical procedures. India's market for enflurane is influenced by its growing healthcare infrastructure, increased accessibility to medical facilities, and cost sensitivity. The balance between affordability and efficacy plays a critical role in enflurane's adoption in the Indian market.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Enflurane Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Enflurane Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Enflurane Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Baxter International, Inc., Boehringer Ingelheim International GmbH, Dragerwerk AG & Co. KGaA, GE HealthCare Technologies Inc., Hikma Pharmaceuticals PLC, J&TEC CO., LTD., and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Enflurane Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Route of Administration
  • Inhalation
  • Oral

• End-Use
  • Ambulatory Surgical Centers
  • Hospitals

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Enflurane Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Enflurane Market?

3. What are the technology trends and regulatory frameworks in the Enflurane Market?

4. What is the market share of the leading vendors in the Enflurane Market?

5. Which modes and strategic moves are suitable for entering the Enflurane Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidences of chronic diseases and accidents globally
    • 5.1.1.2. Increasing preference for enflurane among anesthesiologists for surgeries requiring short- to medium-term anesthesia
  • 5.1.2. Restraints
    • 5.1.2.1. Emergence of newer and advanced anesthetic agents
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological innovations in anesthesia delivery and monitoring techniques
    • 5.1.3.2. Ongoing research into biodegradable, eco-friendly alternatives
  • 5.1.4. Challenges
    • 5.1.4.1. Regulatory scrutiny and stringent guidelines governing the use of enflurane
• 5.2. Market Segmentation Analysis
  • 5.2.1. Route of Administration: Increasing administration of enflurane via inhalation
  • 5.2.2. End-Use: Evolving usage of enflurane by hospitals
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Enflurane Market, by Route of Administration

• 6.1. Introduction
• 6.2. Inhalation
• 6.3. Oral

7. Enflurane Market, by End-Use

• 7.1. Introduction
• 7.2. Ambulatory Surgical Centers
• 7.3. Hospitals

8. Americas Enflurane Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Enflurane Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Enflurane Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
  • 11.3.1. SunMed Completes Acquisition Of Respiratory & Anesthesia Consumables Business Of Vyaire Medical
• 11.4. Strategy Analysis & Recommendation

12. Competitive Portfolio

• 12.1. Key Company Profiles
• 12.2. Key Product Portfolio